MTEMQ — Molecular Templates Share News
0.000.00%
Last trade - 00:00- $0.00m
- -$9.66m
- $57.31m
U.S. STOCKS ON THE MOVE-Immunome, Tilray, Facebook, Osprey Tech
U.S. STOCKS ON THE MOVE-Facebook, Molecular Templates, Hyatt, SunPower
Molecular Templates slides on $76 mln equity offering
Brief: Molecular Templates Announces Pricing Of $75.9 Million Public Equity Offering
Molecular Templates: Soars on deal with Bristol-Myers to develop cancer therapies
Brief: Molecular Templates Establishes Multi-Target Collaboration With Bristol Myers Squibb For The Discovery And Development Of Next Generation Engineered Toxin Bodies For The Treatment Of Cancer
Brief: Molecular Templates Announces FDA Acceptance Of IND Application For MT-6402
Brief: Molecular Templates, Inc. Provides Update On MT-5111 Phase 1 Study
Molecular Templates: Falls as FDA puts cancer studies on hold after death of patient
Brief: Molecular Templates, Inc. Reports Third Quarter 2020 Financial Results And Provides A Corporate Update
Brief: Molecular Templates Files For Mixed Shelf Of Up To $300 Million
Brief: Molecular Templates Reports Second Quarter Results
Brief: Molecular Templates, Inc. Raises $43 Million In Gross Proceeds Through Its At-The-Market Facility
Brief: Molecular Templates Files For Shelf Of Upto 9.4 Mln Shares By Selling Stockholders
Brief: Molecular Templates Inc Announces $45 Mln Debt Financing From K2 Healthventures
Brief: Molecular Templates Posts Q1 Loss Per Share Of $0.48
Brief: Molecular Templates Reports Fourth Quarter 2019 Financial Results
Brief: Molecular Templates - Ind Is Expected To Be Filed And Phase 1 Study For MT-6402 Is Expected To Be Initiated In 2H20
Molecular Templates: Rises on pricing of $50 mln public equity offer